Kezar Life Sciences (KZR) Leases (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Leases for 5 consecutive years, with $749000.0 as the latest value for Q4 2025.
- Quarterly Leases fell 60.29% to $749000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $749000.0 through Dec 2025, down 60.29% year-over-year, with the annual reading at $749000.0 for FY2025, 60.29% down from the prior year.
- Leases hit $749000.0 in Q4 2025 for Kezar Life Sciences, down from $1.0 million in the prior quarter.
- In the past five years, Leases ranged from a high of $9.7 million in Q4 2022 to a low of $749000.0 in Q4 2025.
- Historically, Leases has averaged $3.7 million across 5 years, with a median of $2.6 million in 2021.
- Biggest five-year swings in Leases: skyrocketed 268.25% in 2023 and later plummeted 73.45% in 2024.
- Year by year, Leases stood at $2.7 million in 2021, then surged by 258.92% to $9.7 million in 2022, then plummeted by 50.95% to $4.8 million in 2023, then crashed by 60.53% to $1.9 million in 2024, then plummeted by 60.29% to $749000.0 in 2025.
- Business Quant data shows Leases for KZR at $749000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.3 million in Q2 2025.